What's happening
This bill requires Medicaid to cover remotely connected insulin pens for diabetic patients, including children with adult supervision.
Why it matters
Expands access to advanced diabetes technology. by mandating Medicaid coverage for remotely connected insulin pens, which can improve disease management and outcomes for patients who might otherwise struggle with traditional insulin delivery.
Addresses pediatric needs. by allowing children under seven to use these devices with adult supervision, helping families manage childhood diabetes more safely and conveniently at home.
Requires managed care organizations to account for costs. associated with both the devices and their administration in premium payments, which could influence how Medicaid plans budget and negotiate for diabetes care.
May encourage broader adoption and innovation. in digital health tools for diabetes management by making them more accessible to low-income populations, potentially reducing long-term healthcare costs through better disease control.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Headline styles
Cover Remotely Connected Insulin Pens
Plain English, a few words. Used as the page title.
Sponsors
No co-sponsors yet.
History
- Referred to health
- Referred to health
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Cover Smart Insulin Pens
In Assembly Committee · Health · Sponsor Kimberly Jean-Pierre
Full text
1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
7097
2021-2022 Regular Sessions
IN SENATE
May 28, 2021
Introduced by Sen. COONEY -- read twice and ordered printed, and when printed to be committed to the Committee on Health
AN ACT to amend the social services law, in relation to coverage for assistance for remotely connected insulin pens for certain patients with diabetes
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Subdivision 2 of section 365-a of the social services law is amended by adding a new paragraph (ii) to read as follows:
(ii) Remotely connected insulin pens for patients with diabetes that can operate interactively and/or autonomously for recipients who are seven years of age or older and will be using such a device solely with appropriately prescribed insulin cartridges; provided recipients younger than seven years old may use the remotely connected insulin delivery device with adult supervision. Coverage of such remotely connected insulin pens shall be provided under the pharmacy benefit of medical assistance for all eligible patients with diabetes and the cost of such services, including the cost to administer such benefit, shall be adequately reflected in managed care organization premium payments.
§ 2. This act shall take effect January 1, 2022.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD11732-01-1
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Sponsor's memo
Title of bill
An act to amend the social services law, in relation to coverage for assistance for remotely connected insulin pens for certain patients with diabetes
Summary of specific provisions
Section one requires that remotely connected insulin pens for patients with diabetes that can operate interactively and/or autonomously shall be covered under the pharmacy benefit of medical assistance for all eligible patients with diabetes and the cost of such services shall be reflected in managed care organization premium payments.
Section two provides the effective date.
Justification
Insulin pens are a life-saving device for many with diabetes, and the technology for these pens is ever-evolving. Certain new insulin pens have wireless capability, allowing users to operate and administer via mobile app. Such apps can keep track of insulin and glucose levels, send reminders to dose, and even create multi-monthly reports for users to more effectively manage their health.
New technology, like these insulin pens, has to be approved for inclu- sion in Medicaid by the Medicaid Evidence-Based Benefit Review Advisory Committee within the Department of Health. However, as this committee has not met since 2017, Medicaid recipients across the state are deprived of these new devices that can help better manage their condi- tions. In the absence of action by the committee, adding these new insu- lin pens to Medicaid coverage in the law is the only way those with diabetes will have access to this technology that may save their lives.
Prior legislative history
This is a new bill.
Fiscal implication
To be determined.
Effective date
This act shall take effect January 1, 2022.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.